Polymorphisms inXRCC1,XRCC3, andCCND1and Survival After Treatment for Metastatic Breast Cancer
- 20 December 2006
- journal article
- breast cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (36) , 5645-5651
- https://doi.org/10.1200/jco.2006.05.9923
Abstract
Purpose Single nucleotide polymorphisms (SNPs) in DNA repair and cell cycle control genes may alter protein function and therefore the efficacy of DNA damaging chemotherapy. We retrospectively eval...Keywords
This publication has 61 references indexed in Scilit:
- Cyclin D1: polymorphism, aberrant splicing and cancer riskOncogene, 2006
- Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinomaCancer, 2005
- New developments in the treatment of metastatic breast cancer: from chemotherapy to biological therapyAnnals of Oncology, 2005
- GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in SingaporeEuropean Journal Of Cancer, 2005
- Nucleotide-excision repair and prostate cancer riskCancer Letters, 2005
- Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancerBreast Cancer Research and Treatment, 2005
- Cyclin D1 A870G polymorphism and amplification in laryngeal squamous cell carcinoma: implications of tumor localization and tobacco exposureCancer Detection Prevention, 2004
- Cyclin D1, p53, and p21Waf1/Cip1 Expression Is Predictive of Poor Clinical Outcome in Serous Epithelial Ovarian CancerClinical Cancer Research, 2004
- DNA repair gene XRCC2 and XRCC3 polymorphisms and susceptibility to cancers of the upper aerodigestive tractInternational Journal of Cancer, 2004
- DNA repair gene XRCC1 polymorphisms, smoking, and esophageal cancer riskCancer Detection Prevention, 2004